Transcript
A (0:01)
I'm Dave Asprey. That's Dave spelled D A I V E. And this is your 10 minute weekly upgrade on the biggest stories in biohacking, longevity and the world of health. Let's go.
B (0:16)
You see it in the mirror. Wrinkles, sagging and old scars your skincare can't touch. What if you could get cosmetic surgery results at home without the pain, the risk or the downtime? The Lima laser switches your skin into youth mode. This is clinic grade cold laser technology now available at home. It penetrates deep into your skin and triggers repair at the cellular level, not just the surface. Watch your wrinkles, scars and pigmentation fade, all without stepping into a clinic. No surgery or injections necessary. Experts around the world trust and use this. I use this. If you're serious about changing how your skin looks and feels, this is the future. Go to Lima Life and use code DAVE10 for 10% off the Lima laser. That's L Y M A dot life and use code DAVE10.
A (1:11)
Story 1 Rapamycin hype check. A major review from Agingus.com on September 24th is calling out the gap between animal wins and human reality translation in healthy adults. Clinical evidence for lifespan or true aging reversal just isn't there yet. And safety flags mean we need longer, better trials before people pop it off label like a vitamin. I've said this before. MTOR is powerful, rapamycin is interesting. But lifestyle levers hit the same pathway with fewer unknowns. Fasting, protein timing, intelligent training. Use data, guys, not dogma. Sennalytics just leveled up on September 23. New data showed why results have been all over the map. Senescent cells aren't one thing, they're a zoo. And their kill switches change with cell cycle status. Translation? If you don't match the senolytic to the senescent subtype and timing, you're swinging a baseball bat in the dark.
B (2:16)
Why?
A (2:17)
This matters for your biology right now. Senescent cells drive inflammation, steal nutrients and jam mitochondrial signaling. Clear the right ones and you free up recovery capacity. Clear the wrong ones and you stress healthy cells. Or you just waste time and money. Precision beats carpet bombing. Always. This also explains why early stacks with quercetin hit different tissues differently and why some people felt joint relief while others felt nothing. Different senescent subtypes, different survival programs, different tissues. How to use this today without pretending we have final answers? Think hit and run, not daily drip. Intermittent dosing respects the threshold nature of zombie cells and reduces collateral stress. Pair with cleanup support. Autophagy and membrane integrity so healthy cells rebound faster. Hrv, sleep efficiency, joint comfort training, recovery and basic inflammation markers pre and post acenolytic cycle. Don't stack blindly. If you're using a senolytic protocol, change one variable at a time and watch for tissue specific effects over two to six weeks. My take this is the turning point from senolytics kind of work sometimes to senolytics work when targeted. Expect protocols that subtype cells time dosing to cell status and combine with immune support to finish the cleanup. That's how we move from Internet lore to real world rejuvenation. AI in healthcare is exploding and doctors are nervous as of a news report from Crescendo AI on September 23, projections pegged the AI and healthcare market marching toward roughly the hundred billion plus zone by 2030. Huge upside in personalization, faster pattern finding and taking drudgery off clinicians plates. But about 70% of surveyed physicians still don't trust it for diagnostics. My read Use AI as a co pilot for data triage, not an oracle for life and death calls. Alright, this one matters. AI is stepping between you and your doctor. A new federal pilot would let algorithms approve or deny Medicare coverage, essentially scaling prior authorization by machine. That dropped in Thursday's policy rundown from kffhealthnews.org and it's the kind of quiet change that rewires care without a vote, a hearing, or your consent. Here's the core issue. Prior authorization already delays treatment and burns clinician hours. Now imagine it turbocharged by an opaque model trained on past denials and cost controls. If the ruleset isn't transparent, explainable and appealable, the the algorithm becomes a financial bouncer at the clinic door. You won't even know which variable kicked you out. Age code, zip, or some proxy for low value. I'm not anti AI, I'm pro agency. AI should be a co pilot that flags fraud and speeds approvals for obvious wins. Not a black box that quietly labels your therapy low value while your condition worsens. If we're going to do this, we need three guardrails. Explainability in plain English a a fast human override and auditable logs you can actually see. No secrets, no computer says no why this hits medical freedom. Edge cases are where innovation lives. The people who benefit most from unconventional care are the first to get squeezed by one size fits all models. That's why I'm drawing a line here. Use AI to cut friction, not to ration hope. Again, this isn't speculation, it's it's the practical consequence of the Medicare AI pilot and it deserves heat while it's still a pilot, not a default. What to do right now if you or your parents touch Medicare, start documenting medical necessity today. Keep copies of notes, labs failed, standard therapies. Ask the plan in writing, what model is used, what features drive denials, what's the human review process and and what's the turnaround time for appeals if they can't answer clearly, that's the problem. Push for sunlight before the switch flips. Bottom line, AI should widen access, not narrow it. Make it transparent. Keep humans accountable. Protect the right to pursue care at the edges.